Rituximab in neurological disease: principles, evidence and practice
Daniel Whittam(University of Liverpool), Anu Jacob(Abu Dhabi University)
Cited by 96
Related Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
Treatment of Neuromyelitis Optica With Rituximab
|Archives of Neurology|2008|460
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
|Frontiers in Neurology|2020|399